Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | KCNN4 | O15554 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trimethylammonium SCHEMBL28646670 | 0.87 | KCNN4 (0.55) | ALDH1A1KCNN4TSHRMAPK1TAAR1 | |
| Sulfur Dioxide SCHEMBL28914858 | 0.87 | KCNN4 (0.41) | ALDH1A1KCNN4TSHRMAPK1TDP1 | |
| SCHEMBL1538898 | 0.77 | ALDH1A1 (0.50) | ALDH1A1KCNN4TSHRMAPK1TDP1 | |
| SCHEMBL21647231 | 0.77 | ALDH1A1 (0.50) | ALDH1A1KCNN4TSHRMAPK1TDP1 | |
| Bromotriphenylmethane SCHEMBL263 | 0.77 | ALDH1A1 (0.50) | ALDH1A1KCNN4TSHRMAPK1TDP1 | |
| SCHEMBL1538551 | 0.74 | PGK1 (0.39) | ALDH1A1KCNN4TSHRMAPK1TAAR1 | |
| SCHEMBL642315 | 0.74 | TAAR1 (0.57) | ALDH1A1KCNN4TSHRMAPK1TAAR1 | |
| Bromotriphenylmethane SCHEMBL2379015 | 0.74 | KCNN4 (0.47) | ALDH1A1KCNN4TSHRMAPK1TDP1 | |
| Bromotriphenylmethane SCHEMBL113031 | 0.74 | KCNN4 (0.47) | ALDH1A1KCNN4TSHRMAPK1TDP1 | |
| Bromotriphenylmethane SCHEMBL2141926 | 0.74 | KCNN4 (0.47) | ALDH1A1KCNN4TSHRMAPK1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 630 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119284855-A | Preparation method of lithium iron manganese phosphate battery positive electrode material | 广西金茂钛业股份有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-118572161-A | Anion exchange membrane of all-iron flow battery and preparation method and application thereof | 中国科学院金属研究所 | 2024-08-30 | — | — | CN | claimed |
| CN-118344586-A | Ion covalent organic polymer material and preparation method and application thereof | 河北工程大学 | 2024-07-16 | — | — | CN | claimed |
| CN-118085313-A | Polyion liquid-metal organic framework composite material and preparation method and application thereof | 福州大学 | 2024-05-28 | — | — | CN | claimed |
| US-20240117005-A1 | NOVEL BICYCLIC PEPTIDES | THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH (AU) | 2024-04-11 | — | — | US | claimed |
| CN-117820159-A | Synthesis method of 3,3' -dihydroxyazobenzene and hyperbranched azobenzene derived from same | 河南省科学院高新技术研究中心 | 2024-04-05 | — | — | CN | claimed |
| CN-117487139-A | Covalent organic polymer based on tetrastyrene group, preparation method and application thereof | 华南理工大学 | 2024-02-02 | — | — | CN | claimed |
| CN-114656525-B | RGD cyclic peptide for cancer cell integrin and application thereof in preparation of tumor drugs | 合肥师范学院 | 2024-02-02 | — | — | CN | claimed |
| US-11845769-B2 | Anion exchange stationary phases based on a polyalkylpolyamine polymer layer | DIONEX CORPORATION (US) | 2023-12-19 | — | — | US | claimed |
| EP-4281486-A1 | NOVEL BICYCLIC PEPTIDES | The Council of the Queensland Institute of Medical Research (AU) | 2023-11-29 | — | — | EP | claimed |
| EP-0036352-B1 | PROCESS FOR THE PREPARATION OF TRIFLUOROMETHYL BENZENES FROM THE CORRESPONDING TRICHLORO OR TRIBROMO METHYL BENZENES | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1983-06-01 | — | — | EP | claimed |
| US-4359426-A | Process for the production of aromatic isocyanates containing aromatically bound sulfochloride groups | BAYER AKTIENGESELLSCHAFT (DE) | 1982-11-16 | — | — | US | claimed |
| EP-0003263-B1 | A METHOD OF FORMING AN IMAGE, AND AN IMAGING ELEMENT FOR INHIBITING IMAGE FORMATION WITH COBALT (III) COMPLEXES | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1982-09-29 | — | — | EP | claimed |
| EP-0045431-A1 | Process for the side-chain bromination of toluenes and mixtures of toluenes diversly highly brominated in the side chain | BAYER AG (DE) | 1982-02-10 | — | — | EP | claimed |
| EP-0011288-B1 | P-TERT.-BUTYLBENZOTRIBROMIDE AND HIS DERIVATIVES WHICH ARE SUBSTITUTED IN THE RING BY HALOGEN, A PROCESS FOR THEIR PREPARATION AS WELL AS THEIR USE. | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-01-20 | — | — | EP | claimed |
| EP-0036352-A1 | Process for the preparation of trifluoromethyl benzenes from the corresponding trichloro or tribromo methyl benzenes | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1981-09-23 | — | — | EP | claimed |
| EP-0034711-A2 | Process for preparing aromatic isocyanates with aromatically bound sulfochloride groups | BAYER AG (DE) | 1981-09-02 | — | — | EP | claimed |
| EP-0003263-A1 | A method of forming an image, and an imaging element for inhibiting image formation with cobalt (III) complexes | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1979-08-08 | — | — | EP | claimed |
| WO-1979000448-A1 | INHIBITING IMAGE FORMATION WITH COBALT(III)COMPLEXES | EASTMAN KODAK CO (US) | 1979-07-26 | — | — | WO | claimed |
| US-4013817-A | HALOGENATED AROMATIC HYDROCARBON | BRIDGESTONE TIRE COMPANY LIMITED (JA) | 1977-03-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240117005-A1 | NOVEL BICYCLIC PEPTIDES | PDCD1LG2, PDCD1, CD274 | ALDH1A1 3941/4885KCNN4 4870/4885TSHR 1724/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.